Hancock Jaffe Laboratories is a medical devices business based in the US. Hancock Jaffe Laboratories shares (HJLI) are listed on the NASDAQ and all prices are listed in US Dollars. Hancock Jaffe Laboratories employs 19 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $9.02 |
| 200-day moving average | $6.95 |
| Wall St. target price | $26.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.71 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $N/A from 2021-12-08
| 1 week (2024-07-12) | N/A |
|---|---|
| 1 month (2024-06-19) | N/A |
| 3 months (2024-04-19) | N/A |
| 6 months (2024-01-19) | N/A |
| 1 year (2023-07-19) | N/A |
|---|---|
| 2 years (2022-07-19) | N/A |
| 3 years (2021-07-23) | -100.00% |
| 5 years (2019-07-23) | -100.00% |
| Gross profit TTM | $-4,252,249 |
|---|---|
| Return on assets TTM | -30.58% |
| Return on equity TTM | -55.76% |
| Profit margin | 0% |
| Book value | $4.80 |
| Market Capitalization | $98.3 million |
TTM: trailing 12 months
We're not expecting Hancock Jaffe Laboratories to pay a dividend over the next 12 months.
Hancock Jaffe Laboratories's shares were split on a 1:25 basis on 29 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hancock Jaffe Laboratories shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hancock Jaffe Laboratories shares which in turn could have impacted Hancock Jaffe Laboratories's share price.
Over the last 12 months, Hancock Jaffe Laboratories's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hancock Jaffe Laboratories's is 1.5404. This would suggest that Hancock Jaffe Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Hancock Jaffe Laboratories, Inc. , a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA. .
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
A deep dive into the highlights and limitations of Frec.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.